Novozymes A/S (NVZMY) Expected to Release Earnings on Thursday

Novozymes A/S (OTCMKTS:NVZMY) is anticipated to issue its results before the market opens on Thursday, November 5th. Analysts expect Novozymes A/S to post earnings of $0.7630 per share and revenue of $1.29 billion for the quarter.

Novozymes A/S (OTCMKTS:NVZMY) last announced its quarterly earnings results on Thursday, August 20th. The biotechnology company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.16). Novozymes A/S had a return on equity of 6.54% and a net margin of 14.70%. The firm had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.27 billion. On average, analysts expect Novozymes A/S to post $2.45 EPS for the current fiscal year and $2.64 EPS for the next fiscal year.

Novozymes A/S Price Performance

NVZMY stock opened at $69.31 on Tuesday. Novozymes A/S has a one year low of $49.90 and a one year high of $75.27. The firm has a 50 day simple moving average of $67.64 and a two-hundred day simple moving average of $62.58. The stock has a market cap of $28.73 billion, a PE ratio of 38.96, a P/E/G ratio of 3.11 and a beta of 0.89. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.74 and a quick ratio of 1.04.

About Novozymes A/S

Novozymes A/S was a Denmark-based biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its products were designed to help customers improve manufacturing processes, reduce resource consumption and develop more sustainable alternatives to conventional chemicals and production methods.

The company served a broad range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing.